
Please try another search
Orchestra BioMed Holdings, Inc. operates as a biomedical company in the United States. The company’s flagship product candidates include Atrioventricular Interval Modulation, a bioelectronic therapy candidate designed to immediately, substantially, and persistently lower blood pressure; and Virtue Sirolimus AngioInfusion Balloon for the treatment of atherosclerotic artery disease. It also develops Cardiac Neuromodulation Therapy for heart failure, or potential treatment of clinical indications; and CNT-HF, a bioelectronic product candidate that aims to reduce chronic sympathetic nervous system activity in heart failure. In addition, the company offers FreeHold devices and additional minimally invasive surgery enabling devices; and Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during colonoscopy and upper gastrointestinal endoscopy procedures. It has a collaboration agreement with Medtronic, Inc. for the development of AVIM therapy for the treatment of HTN in pacemaker-indicated patients; and a strategic collaboration with Terumo Corporation and Terumo Medical Corporation for the development and commercialization of Virtue SAB for the treatment of coronary and peripheral artery disease. Orchestra BioMed Holdings, Inc. was founded in 2018 and is headquartered in New Hope, Pennsylvania.
Name | Age | Since | Title |
---|---|---|---|
Carsten Boess | 54 | 2020 | Independent Director |
Roderick T. Wong | 44 | 2020 | President, CEO & Chairman |
Pedro P. Granadillo | 73 | 2020 | Independent Director |
Stuart W. Peltz | 61 | 2020 | Independent Director |
David C. Pacitti | 57 | 2024 | Independent Director |
David P. Hochman | 50 | 2018 | Founder, Chairman of the Board of Directors & CEO |
Darren R. Sherman | 54 | 2018 | Founder, President, COO & Director |
Jagmeet P. Singh | - | - | Member of Medical Advisors Board |
Pieter Stella | - | - | Member of Medical Advisors Board |
Karl-Heintz Kuck | - | - | Member of Medical Advisors Board |
Barry T. Katzen | 78 | - | Member of Medical Advisors Board |
Juan F. Granada | - | - | Member of Medical Advisors Board |
Stefan Verheye | - | - | Member of Medical Advisors Board |
Paul S. Teirstein | - | - | Member of Medical Advisors Board |
Jason M. Aryeh | 57 | 2018 | Independent Director |
Eric S. Fain | 64 | 2018 | Independent Lead Director |
Pamela Yanchik Connealy | 63 | 2020 | Independent Director |
Gregg W. Stone | 68 | - | Member of Medical Advisors Board |
Vivek Y. Reddy | - | - | Member of Medical Advisors Board |
Roger A. de la Torre | - | - | Member of Medical Advisors Board |
Daniel Burkhoff | - | - | Member of Medical Advisors Board |
Robert S. Schwartz | - | - | Member of Medical Advisors Board |
Angelo Auricchio | - | - | Member of Medical Advisors Board |
Dean J. Kereiakes | - | - | Member of Medical Advisors Board |
John M. Flack | - | - | Member of Medical Advisors Board |
David E. Kandzari | - | - | Member of Medical Advisors Board |
J. Stephen Scott | - | - | Member of Medical Advisors Board |
Christopher Michael Cleary | 64 | 2025 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review